Annual report pursuant to Section 13 and 15(d)

Equity Compensation Plans - Stock Options Narrative (Details)

v3.20.4
Equity Compensation Plans - Stock Options Narrative (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Stock Option Disclosures      
Proceeds from exercise of stock options $ 3,300 $ 4,002 $ 3,884
Prior Axogen Plan | Minimum      
Stock Option Disclosures      
Vesting period (in years) 7 years    
Prior Axogen Plan | Maximum      
Stock Option Disclosures      
Vesting period (in years) 10 years    
2017 ESPP | Tranche Two      
Stock Option Disclosures      
Vesting period (in years) 2 years    
Stock options | Prior Axogen Plan      
Stock Option Disclosures      
Vesting period (in years) 4 years    
Stock options | Prior Axogen Plan | One Year After Grant Date      
Stock Option Disclosures      
Vesting percentage 25.00%    
Vesting period (in years) 1 year    
Stock options | Prior Axogen Plan | Tranche Two      
Stock Option Disclosures      
Vesting percentage 12.50%    
Vesting period (in years) 3 years    
Stock options | 2017 ESPP      
Stock Option Disclosures      
Vesting period (in years) 4 years    
Stock options | 2017 ESPP | Tranche Two      
Stock Option Disclosures      
Vesting percentage 12.50%    
Stock options | 2017 ESPP | Tranche One      
Stock Option Disclosures      
Vesting percentage 50.00%    
Vesting period (in years) 2 years    
Directors And Officers Stock Options | Per Quarter, Over One Year      
Stock Option Disclosures      
Vesting percentage 25.00%    
Vesting period (in years) 1 year    
Directors And Officers Stock Options | 2017 ESPP      
Stock Option Disclosures      
Vesting period (in years) 3 years